FAIRFAX, Va. — Vizuri Health Sciences announced that the company has further strengthened its consumer healthcare operational and transactional experience by adding Elise Donahue to its board of directors.

William Moore, Vizuri’s chief executive officer stated, “We are delighted to have Elise join the Vizuri Board. Her extensive consumer packaged goods experience, evidenced by her significant accomplishments, will serve Vizuri well as the company grows its consumer healthcare business following the launch of its over-the-counter topical analgesic product PainBloc24. The commercial launch of PainBloc24 and the recent initiation of a Phase 2 osteoarthritis knee pain study for Vizuri’s prescription-strength capsaicin product underscore our commitment to develop safe, effective, and convenient non-opiate products for the treatment of chronic pain. We believe that our topical capsaicin product franchise will provide osteoarthritis sufferers a spectrum of safe and effective dose-strength options for the management of nerve pain.”

Elise Donahue added, “I am excited to be joining Vizuri’s board of directors as PainBloc24 retail distribution and sales ramp up. I look forward to working with other members of the board to help Vizuri’s consumer healthcare business attain profitability.”

Donahue has led the growth of several consumer product companies (including South Beach Diet, Prestige Brands International, Airborne Health, and Slim Fast/Thomson Medical, the latter which developed and marketed the Capzasin topical analgesic line). She also served as a Management Affiliate at the private equity fund, MidOcean Partners, and has served on the board of directors of several U.S. and Europe consumer healthcare companies.